Europe - Frankfurt Stock Exchange - FRA:NOVC - DK0060534915 - Common Stock
NOVC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While NOVC belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. NOVC is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, NOVC could be worth investigating further for growth investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.95% | ||
| ROE | 74.32% | ||
| ROIC | 55.96% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.8% | ||
| PM (TTM) | 33.4% | ||
| GM | 84.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 0.38 | ||
| Altman-Z | 11.18 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.7 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.17 | ||
| Fwd PE | 15.13 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.68 | ||
| EV/EBITDA | 30.33 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ChartMill assigns a fundamental rating of 7 / 10 to NOVC.DE.
ChartMill assigns a valuation rating of 4 / 10 to (NOVC.DE). This can be considered as Fairly Valued.
(NOVC.DE) has a profitability rating of 9 / 10.
The financial health rating of (NOVC.DE) is 7 / 10.
The dividend rating of (NOVC.DE) is 4 / 10 and the dividend payout ratio is 41.57%.